BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2869851)

  • 1. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.
    Mielants H; Veys EM; Joos R
    Clin Rheumatol; 1986 Jan; 5(1):80-3. PubMed ID: 2869851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroscopic and histological changes of the ileum HLA-B27 related diseases: therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Int J Clin Pharmacol Res; 1984; 4(6):409-14. PubMed ID: 6152438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
    Dougados M; Boumier P; Amor B
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine in ankylosing spondylitis.
    Feltelius N; Hällgren R
    Ann Rheum Dis; 1986 May; 45(5):396-9. PubMed ID: 2872857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the seronegative spondyloarthropathies with sulfasalazine.
    Zwillich SH; Comer SS; Lee E; Erdman WA; Lipsky PE
    J Rheumatol Suppl; 1988 Sep; 16():33-9. PubMed ID: 2903925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulfasalazine therapy in spondylarthritis ankylopoietica].
    Winkler V
    Orv Hetil; 1989 Jan; 130(2):77-81. PubMed ID: 2563308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect.
    Corkill MM; Jobanputra P; Gibson T; Macfarlane DG
    Br J Rheumatol; 1990 Feb; 29(1):41-5. PubMed ID: 1968354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sulphasalazine in ankylosing spondylitis--an interventional study.
    Fraser SM; Sturrock RD
    Br J Rheumatol; 1990 Feb; 29(1):37-9. PubMed ID: 1968353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.
    Clegg DO; Reda DJ; Weisman MH; Blackburn WD; Cush JJ; Cannon GW; Mahowald ML; Schumacher HR; Taylor T; Budiman-Mak E; Cohen MR; Vasey FB; Luggen ME; Mejias E; Silverman SL; Makkena R; Alepa FP; Buxbaum J; Haakenson CM; Ward RH; Manaster BJ; Anderson RJ; Ward JR; Henderson WG
    Arthritis Rheum; 1996 Dec; 39(12):2004-12. PubMed ID: 8961905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis.
    Mielants H; Veys EM
    J Rheumatol; 1985 Apr; 12(2):287-93. PubMed ID: 2863376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
    Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
    J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization to sulphasalazine in patients with arthritis.
    Koski JM
    Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
    Huang JL; Hung IJ; Hsieh KH
    Asian Pac J Allergy Immunol; 1997 Jun; 15(2):71-5. PubMed ID: 9346269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine for ankylosing spondylitis.
    Chen J; Liu C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sulfasalazine in the treatment of ankylosing spondylitis].
    Krajnc I
    Lijec Vjesn; 1990; 112(5-6):171-4. PubMed ID: 1978212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
    Suschke HJ
    Monatsschr Kinderheilkd; 1992 Sep; 140(9):658-60. PubMed ID: 1359405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial palsy and partial accommodative insufficiency associated with sulphasalazine treatment in a patient with ankylosing spondylitis.
    Magnus JH; Elverland HH; Olsen EG; Husby G
    Scand J Rheumatol; 1993; 22(4):199-201. PubMed ID: 8102809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical involvement of the gut in undifferentiated spondylarthropathies.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Clin Exp Rheumatol; 1989; 7(5):499-504. PubMed ID: 2591124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years.
    Kirwan J; Edwards A; Huitfeldt B; Thompson P; Currey H
    Br J Rheumatol; 1993 Aug; 32(8):729-33. PubMed ID: 8102305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
    Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
    Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.